Huang, Xuan
Shu, Qing
Luo, Xuemei
Ge, Weihong
Xie, Han
Zhou, Yujie
Funding for this research was provided by:
Jiangsu Research Hospital Association (YJ202112)
Jiangsu Pharmaceutical Association (Q202213)
Article History
Received: 5 August 2023
Accepted: 1 September 2023
First Online: 27 September 2023
Declarations
:
: Xuan Huang, Han Xie, Qing Shu, Xuemei Luo, Weihong Ge, and Yujie Zhou have nothing to disclose.
: This study protocol was approved by the Ethics Committee of Nanjing Drum Tower Hospital (Approval number: 2021-643-02; Trial registration number: ChiCTR2300070628). All research adhered to the tenets of the Declaration of Helsinki. All subjects gave written informed consent.